KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $8.7 million.

  • Exact Sciences' Short-term Investments fell 9800.63% to $8.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.7 million, marking a year-over-year decrease of 9800.63%. This contributed to the annual value of $8.7 million for FY2025, which is 9800.63% down from last year.
  • As of Q4 2025, Exact Sciences' Short-term Investments stood at $8.7 million, which was down 9800.63% from $214.1 million recorded in Q3 2025.
  • Over the past 5 years, Exact Sciences' Short-term Investments peaked at $944.7 million during Q3 2021, and registered a low of $8.7 million during Q4 2025.
  • For the 5-year period, Exact Sciences' Short-term Investments averaged around $402.9 million, with its median value being $403.1 million (2022).
  • As far as peak fluctuations go, Exact Sciences' Short-term Investments surged by 20924.15% in 2024, and later tumbled by 9800.63% in 2025.
  • Exact Sciences' Short-term Investments (Quarter) stood at $715.0 million in 2021, then tumbled by 45.52% to $389.6 million in 2022, then plummeted by 55.78% to $172.3 million in 2023, then skyrocketed by 153.76% to $437.1 million in 2024, then plummeted by 98.01% to $8.7 million in 2025.
  • Its last three reported values are $8.7 million in Q4 2025, $214.1 million for Q3 2025, and $201.3 million during Q2 2025.